Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Berman

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Future Healthcare Journal|May 18, 2019
Acute medical and specialty support at a tertiary cancer centre: a collaboration to achieve high-quality care for acutely unwell patients with cancerTim Cooksley, Tamer Al-Sayed, Simon Ray, et al.
Advances in Therapy|December 17, 2021
The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United StatesJan Sieluk, Yan Song, Jonathan Freimark, et al.
Journal of Managed Care & Specialty Pharmacy|March 29, 2023
Prevalence of potential drug-drug interactions with ritonavir-containing COVID-19 therapyEbuwa Igho-Osagie, Amy Puenpatom, Marissa Grifasi Williams, et al.
Palliative Medicine|October 19, 2021
<i>'It feels it's wasting whatever time I've got left'</i>: A qualitative study of living with treatable but not curable cancer during the COVID-19 pandemicEloise Radcliffe, Aysha Khan, David Wright, et al.
Plos Medicine|June 9, 2023
Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from HaitiNancy Dorvil, Vanessa R Rivera, Cynthia Riviere, et al.
The Lancet. HIV|November 12, 2023
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trialRaphael J Landovitz, Brett S Hanscom, Meredith E Clement, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Future Healthcare Journal|May 18, 2019
Acute medical and specialty support at a tertiary cancer centre: a collaboration to achieve high-quality care for acutely unwell patients with cancerTim Cooksley, Tamer Al-Sayed, Simon Ray, et al.
Advances in Therapy|December 17, 2021
The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United StatesJan Sieluk, Yan Song, Jonathan Freimark, et al.
Journal of Managed Care & Specialty Pharmacy|March 29, 2023
Prevalence of potential drug-drug interactions with ritonavir-containing COVID-19 therapyEbuwa Igho-Osagie, Amy Puenpatom, Marissa Grifasi Williams, et al.
Palliative Medicine|October 19, 2021
<i>'It feels it's wasting whatever time I've got left'</i>: A qualitative study of living with treatable but not curable cancer during the COVID-19 pandemicEloise Radcliffe, Aysha Khan, David Wright, et al.
Plos Medicine|June 9, 2023
Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from HaitiNancy Dorvil, Vanessa R Rivera, Cynthia Riviere, et al.
The Lancet. HIV|November 12, 2023
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trialRaphael J Landovitz, Brett S Hanscom, Meredith E Clement, et al.
Pageof 3